Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells

Oncogene

Volumn 16, Issue 25, 1998, Pages 3253-3260

  Marchetti, Dario ^a   Parikh, Nila ^a   Sudol, Marius ^b   Gallick, Gary E ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastatic melanoma; c Src; c Yes; Nerve growth factor; Neurotrophin 3; Neurotrophins

Indexed keywords

NEUROTROPHIN; PROTEIN TYROSINE KINASE;

ARTICLE; BRAIN METASTASIS; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS POTENTIAL; ONCOGENE SRC; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0032566002     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201877     Document Type: Article

References (49)

1. Akslen LA, Hove LM and Hartveit F. (1987). Inv. Metastasis, 7, 253-263.
2. Albino AP, Davis BM and Nanus DM. (1991). Cancer Research, 51, 4815-4820.
3. Barbacid M. (1993). Oncogene, 8, 2033-2044.
4. Barnekow A, Paul E and Schartl M. (1987). Cancer Research, 47, 235-240.
5. Bishop JM. (1991). Cell, 64, 235-248.
6. Bothwell M. (1990). Cell, 65, 915-918.
7. Brickell PM. (1992). Crit. Rev. Oncogenesis, 3, 401-446.
8. Cartwright CA, Mamajiwalla SA, Skolnik SA, Eckhart W and Burgess DR. (1993). Oncogene, 8, 1033-1039.
9. Chao MV. (1992). Neuron, 9, 583-593.
10. Fanning P, Bulovas K, Saini RS, Libertino JA, Joyce AD and Summerhayes IC. (1992). Cancer Res. 52, 1457-1463.
11. Golden A and Brugge JS. (1988). The src oncogene. The oncogene handbook, In: Reddy EP, Skalka AM and Curran T. (eds). Elsevier Science Publishers BV, New York, pp 149-173.
12. Grandori C, Sudol M and Hanafusa H. (1991). Oncogene, 6, 1063-1066.
13. Greene LA and Tischler AS. (1976). Proc. Natl. Acad. Sci. USA, 73, 2424-2428.
14. Gutman M, Singh RK, Radinski R and Bar-Eli M. (1994). Anticancer Res., 14, 1759-1766.
15. Guy CT, Cardiff RD and Muller WJ. (1992). Mol. Cell. Biol., 12, 954-961.
16. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P and Clark WH. (1985). Cancer Res., 45, 5670-5676.
17. Herrmann JL, Menter DG, Hamada J, Hamada J, Marchetti D, Nakajima M and Nicolson GL. (1993). Mol .Biol. Cell, 4, 1205-1216.
18. Hunter T and Cooper JA. (1985). Ann. Rev. Biochem., 54, 897-930.
19. Hunter T. (1997). Cell, 88, 333-346.
20. Ishikawa M, Dennis JW, Man MS and Kerbel RS. (1988a). Cancer Res., 48, 665-670.
21. Ishikawa M, Fernandez B and Kerbel RS. (1988b). Cancer Res., 48, 4897-4903.
22. Jacobovitz EB, Majors JE and Varmus HE. (1984). Cell, 38, 757-765.
23. Kremer NE, D'Arcangelo G, Thomas SM, DeMarco M, Brugge JS and Halegoua S. (1991). J. Cell. Biol., 115, 809-819.
24. Kypta RM, Goldberg Y, Ulug ET and Courtneidge SA. (1990). Cell, 62, 481-492.
25. Lamballe F, Klein Rand Barbacid M. (1991). Cell, 66, 967-979.
26. Lindsay RM, Wiengand SJ, Altar CA and DiStefano P. (1994). TINS, 17(5), 182-190.
27. Loganzo F, Jr Dosik JS, Zhao Y, Vidal MJ, Nanus DM, Sudol M and Albino AP. (1993). Oncogene, 8, 2637-2644.
28. Marchetti D, Menter DG, Jin L, Nakajima M and Nicolson GL. (1993). Int. J. Cancer, 55, 692-699.
29. Marchetti D, McCutcheon I, Ross HI and Nicolson GL. (1995). Int. J. Oncol., 7, 87-94.
30. Marchetti D, McQuillan D, Spohn WC, Carson DD and Nicolson GL. (1996). Cancer Res., 56, 2856-2863.
31. Marchetti D and Nicolson GL. (1997a). Advan Enzyme Reg., 37, 111-134.
32. Marchetti D and Nicolson GL. (1997b). J. Inv. Dermatology, 2, 99-105.
33. Nicolson GL. (1993a). Exp. Cell. Res., 204, 171-180.
34. Nicolson GL. (1993b). Cancer Metastasis Rev., 12, 325-343.
35. Nicolson GL, Menter DG, Herrmann JL, Cavanaugh P, Libin L, Hamada J, Yun Z, Nakajima M and Marchetti D. (1994a). Crit. Rev. in Oncogenesis, 5(5), 451-471.
36. Nicolson GL, Nakajima M, Herrmann JL, Menter DG, Cavanaugh P, Park JS and Marchetti D. (1994b). J Neurooncol., 18, 139-149.
37. Nicolson GL and Dulski KM. (1986). Int. J. Cancer, 38, 289-294.
38. O'Connor TJ, Neufeld E, Bechberger J and Fujita DJ. (1992). Cell Growth & Differentiation, 3, 435-442.
39. Ottenhoff-Kalff AE, Rijksen G, van Beurden EACM, Hennipman A, Michels AA and Staal GEJ. (1992). Cancer Research, 52, 4773-4778.
40. Steck PA and Nicolson GL. (1993). Molecular genetics of nervous system tumors, In: A. Levine, H. Schmidek (eds.), Wiley, New York, pp 371-379.
41. Sudol M. (1988). Brain Res. Rev., 13, 391-403.
42. Sudol M. (1992). The molecular basis of human cancer, In: Kumar, R (ed.), Futura Publishing Co., New York.
43. Sudol M, Kuo FC, Shigemitsu L and Alvarez-Buylla A. (1989). Molec. and Cell Biol., 9, 4545-4549.
44. Talamonti MS, Roh MS, Curley SA and Gallick GE. (1993). J. Clin. Invest., 91, 53-61.
45. Termuhlen PM, Curley SA, Talamonti MS, Saboorian MH and Gallick GE. (1993). J. Surg. Research, 54, 293-298.
46. Whittemore SC and Seiger A. (1987). Neurosci. Rev., 12, 439-464.
47. Wright DC and Delaney TF. (1989). Cancer: principles and practice of oncology, In: Vita VT, Hellman S and Rosenberg SA. (eds.), Lippincott, New York, pp 2245-2261.
48. Zhang RD, Price JE, Schackert G, Itoh K and Fidler IJ. (1991). Cancer Res., 51, 2029-2035.
49. Zhao Y-H, Krueger JG and Sudol M. (1990). Oncogene, 5, 1629-1635.